ArticleMedical oncology (Northwood, London, England)2025

Silencing KMT2A with siRNA induces apoptosis and cell cycle arrest in high-grade serous ovarian carcinoma cells by modulating GOF p53-dependent pathways, highlighting its potential as a therapeutic target.

Mohammad Ghanbari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.